Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Inventory Average (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Inventory Average for 15 consecutive years, with $31.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average rose 15.83% to $31.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.1 million, a 15.83% increase, with the full-year FY2025 number at $29.0 million, up 17.37% from a year prior.
  • Inventory Average was $31.1 million for Q4 2025 at Myriad Genetics, up from $30.2 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $31.1 million in Q4 2025 to a low of $15.4 million in Q1 2022.
  • A 5-year average of $23.0 million and a median of $23.4 million in 2023 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: crashed 40.23% in 2022, then surged 42.9% in 2023.
  • Myriad Genetics' Inventory Average stood at $17.0 million in 2021, then increased by 17.11% to $19.8 million in 2022, then increased by 18.64% to $23.6 million in 2023, then increased by 14.01% to $26.8 million in 2024, then grew by 15.83% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Inventory Average are $31.1 million (Q4 2025), $30.2 million (Q3 2025), and $28.5 million (Q2 2025).